These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1181314)

  • 1. Parkinsonism, levodopa, and intelligence.
    Loranger A; Sweet RD; Goodell H; McDowell F
    Int J Neurol; 1975; 10(1-4):276-81. PubMed ID: 1181314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mental disorders in patients with Parkinson's disease treated with L-dopa].
    Piccirilli M; Piccinin GL
    Clin Ter; 1981 Jun; 97(5):473-9. PubMed ID: 7273659
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reports on mental disorders in Parkinson disease in relation to treatment with L-dopa].
    Agostino R; Fabri S
    Riv Neurobiol; 1983; 29(4):577-84. PubMed ID: 6678478
    [No Abstract]   [Full Text] [Related]  

  • 4. Mental disorders in Parkinson's disease after treatment with L-DOPA.
    Rondot P; de Recondo J; Coignet A; Ziegler M
    Adv Neurol; 1984; 40():259-69. PubMed ID: 6695602
    [No Abstract]   [Full Text] [Related]  

  • 5. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A; Grau-Veciana JM
    Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy.
    Botez MI; Barbeau A
    Int J Neurol; 1975; 10(1-4):222-32. PubMed ID: 1181311
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa].
    Haas JA; Lakke JP
    Ned Tijdschr Geneeskd; 1982 Apr; 126(16):701-5. PubMed ID: 7088202
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug treatment of hyperkinesis and mental changes caused by levodopa].
    Presthus J
    Tidsskr Nor Laegeforen; 1975 Jun; 95(16):1009-10. PubMed ID: 1145574
    [No Abstract]   [Full Text] [Related]  

  • 9. [L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments].
    Vasin NIa; Il'inskiĭ IA; Safronov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(5):701-6. PubMed ID: 4454895
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
    Cinca I; Serbănescu A; Tudorache B
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of lithium on the "on-off" phenomenon in parkinsonism.
    Coffey CE; Ross DR; Ferren EL; Bragdon AC; Hurwitz BJ; Olanow CW
    Adv Neurol; 1983; 37():61-73. PubMed ID: 6858779
    [No Abstract]   [Full Text] [Related]  

  • 12. L-tryptophan in the treatment of levodopa induced psychiatric disorders.
    Miller EM; Nieburg HA
    Dis Nerv Syst; 1974 Jan; 35(1):20-3. PubMed ID: 17894051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pergolide treatment in parkinsonism.
    Ilson J; Fahn S; Mayeux R; Cote LJ; Snider SR
    Adv Neurol; 1983; 37():85-94. PubMed ID: 6858780
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems in the administration of L-DOPA (author's transl)].
    Ferrari E
    Riv Patol Nerv Ment; 1974 Aug; 95(4):239-50. PubMed ID: 4283417
    [No Abstract]   [Full Text] [Related]  

  • 15. L-dopa, parkinsonism, and involuntary movements.
    Mayer RF
    Trans Am Neurol Assoc; 1974; 99():163-6. PubMed ID: 4463527
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (3) Side effects of levodopa].
    Mizuno Y
    Rinsho Shinkeigaku; 1976 Dec; 16(12):874-6. PubMed ID: 1035529
    [No Abstract]   [Full Text] [Related]  

  • 17. Mental symptoms in Parkinson's disease during chronic treatment with levodopa.
    Sweet RD; McDowell FH; Feigenson JS; Loranger AW; Goodell H
    Neurology; 1976 Apr; 26(4):305-10. PubMed ID: 944387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects and side effects of levodopa in parkinsonism-results of a collaborative study. (1) Therapeutic responses in relation to the etiology and clinical types].
    Ito K
    Rinsho Shinkeigaku; 1976 Dec; 16(12):869-70. PubMed ID: 1035527
    [No Abstract]   [Full Text] [Related]  

  • 19. Appraisal of long-term levodopa treatment of parkinsonism with special reference to therapy limiting factors.
    Presthus J; Holmsen R
    Acta Neurol Scand; 1974; 50(6):774-90. PubMed ID: 4440452
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tiapride in persistent dyskinesias following long-term L-dopa for parkinsonism].
    Arlazoroff A; Flechtir S; Goldexberg E; Bleicher Z; Barber Y
    Harefuah; 1985 Mar; 108(5):227-9. PubMed ID: 4007677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.